{"url":"https://lda.senate.gov/api/v1/filings/7f5aef7a-8aaa-4eda-b7e0-36d30f613cbf/","filing_uuid":"7f5aef7a-8aaa-4eda-b7e0-36d30f613cbf","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7f5aef7a-8aaa-4eda-b7e0-36d30f613cbf/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Karen Blitz","dt_posted":"2026-05-05T15:07:01-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 Eye Street, NW","registrant_address_2":"Suite 800","registrant_different_address":null,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":314911,"url":"https://lda.senate.gov/api/v1/registrants/314911/","house_registrant_id":39171,"name":"POLSINELLI PC","description":"Law Firm","address_1":"1401 Eye Street, NW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KAREN BLITZ","contact_telephone":"+1 202-783-3300","dt_updated":"2026-07-15T15:35:57.778520-04:00"},"client":{"id":72963,"url":"https://lda.senate.gov/api/v1/clients/72963/","client_id":72963,"name":"NEURIM PHARMACEUTICALS","general_description":"pharmaceutical company","client_government_entity":null,"client_self_select":false,"state":null,"state_display":null,"country":"IL","country_display":"Israel","ppb_state":null,"ppb_state_display":null,"ppb_country":"IL","ppb_country_display":"Israel","effective_date":"2026-04-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Issues relating to FDA regulations relating to pharmaceuticals.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":67393,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":"M","last_name":"GABA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}